Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- Check5 days agoChange DetectedA minor version update was applied: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page revision is updated to v3.3.1, replacing the previous v3.2.0.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved a government funding/operating status notice from the page; the core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check34 days agoChange DetectedThe new screenshot shows a layout change (header/navigation/spacing) with no changes to the actual study details or criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference6%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.